Postoperative Adjuvant Treatment of Completely Resected Mucosal Melanoma Phase II Study
Clinical trial NCT04462965 · UNKNOWN
Trial details
- NCT number
- NCT04462965
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-30
- Primary completion
- 2024-11-30
- Enrollment
- 294
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.